| scholarly article | Q13442814 |
| P2093 | author name string | Peter Laurberg | |
| Göran Wallin | |||
| Mirna Abraham-Nordling | |||
| Göran Lundell | |||
| Leif Tallstedt | |||
| Ove Tørring | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Graves' disease | Q50357588 |
| P304 | page(s) | 69-75 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | European Journal of Endocrinology | Q3060778 |
| P1476 | title | TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study | |
| P478 | volume | 158 |
| Q57136607 | 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism |
| Q33707825 | A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts |
| Q38769722 | Advances in the pharmacological treatment of Graves' orbitopathy |
| Q33655557 | Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence |
| Q37622289 | Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves' Disease Study. |
| Q52715564 | Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy. |
| Q42688833 | Benign thyroid disease in pregnancy: A state of the art review |
| Q43230527 | Blockade of the renin-angiotensin-aldosterone system in Graves' disease |
| Q26852013 | Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity |
| Q41137986 | Case report: clues to the diagnosis of an unsuspected massive levothyroxine overdose. |
| Q87418244 | Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course |
| Q35904885 | Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy |
| Q36238340 | Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients |
| Q36885833 | Clinical review: Clinical utility of TSH receptor antibodies |
| Q64906637 | Clinical utility of TSH receptor antibody levels in Graves' orbitopathy: a comparison of two TSH receptor antibody immunoassays. |
| Q37104833 | Comparison of Early Total Thyroidectomy with Antithyroid Treatment in Patients with Moderate-Severe Graves' Orbitopathy: A Randomized Prospective Trial |
| Q64087412 | Comparison of Five TSH-Receptor Antibody Assays in Graves' disease: results from an observational pilot study |
| Q38827752 | Controversies in the management of Graves' disease in children |
| Q92431771 | DYNAMIC CHANGES OF TRAb AND TPOAb AFTER RADIOIODINE THERAPY IN GRAVES' DISEASE |
| Q95851401 | Diagnosis and Management of Graves' Disease in Thailand: A Survey of Current Practice |
| Q38152621 | Diagnosis and management of Graves disease: a global overview |
| Q48338869 | Does thyroid surgery for Graves' disease improve health-related quality of life? |
| Q41828250 | Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. |
| Q38218911 | Extrathyroidal manifestations of Graves' disease: a 2014 update |
| Q33411594 | Fetal and neonatal thyrotoxicosis |
| Q33579219 | Fetal neonatal hyperthyroidism: diagnostic and therapeutic approachment |
| Q43184328 | Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association. |
| Q37264462 | Graves' Disease that Developed Shortly after Surgery for Thyroid Cancer |
| Q64064984 | Graves' Disease: Can It Be Cured? |
| Q55323533 | Graves' hyperthyroidism in pregnancy: a clinical review. |
| Q37582446 | Graves' orbitopathy: imperfect treatments for a rare disease |
| Q37290885 | Greater Efficacy of Total Thyroidectomy versus Radioiodine Therapy on Hyperthyroidism and Thyroid-Stimulating Immunoglobulin Levels in Patients with Graves' Disease Previously Treated with Antithyroid Drugs |
| Q33594405 | Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016 |
| Q90612381 | Hyperthyroidism |
| Q83683561 | Hyperthyroidism and pregnancy. An Italian Thyroid Association (AIT) and Italian Association of Clinical Endocrinologists (AME) joint statement for clinical practice |
| Q64119695 | Hyperthyroidism in the pregnant woman: Maternal and fetal aspects |
| Q53232463 | Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole. |
| Q38515111 | Important considerations in the management of Graves' disease in pregnant women. |
| Q44153947 | Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease |
| Q38869637 | Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any). |
| Q48125225 | Measuring TSH receptor antibody to influence treatment choices in Graves' disease. |
| Q92827837 | Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.H2h4 Mice |
| Q37356847 | Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease |
| Q52624186 | Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye. |
| Q39666645 | Optimization of current and future therapy for autoimmune diseases |
| Q37869197 | Performance of a third-generation TSH-receptor antibody in a UK clinic |
| Q37290835 | Pre-conception counselling in graves' disease. |
| Q38191709 | Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome? |
| Q34556742 | Preoperative subclinical hyperthyroidism in patients with papillary thyroid carcinoma |
| Q92589776 | Radioiodine therapy and Graves' disease - Myths and reality |
| Q24186122 | Radioiodine therapy versus antithyroid medications for Graves' disease |
| Q36181924 | Radioiodine thyroid ablation in graves' hyperthyroidism: merits and pitfalls |
| Q60045253 | Radioiodine treatment for graves' disease: a 10-year Australian cohort study |
| Q37510140 | Recent developments in hyperthyroidism |
| Q37087157 | Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay |
| Q36194147 | Role of self-tolerance and chronic stimulation in the long-term persistence of adenovirus-induced thyrotropin receptor antibodies in wild-type and transgenic mice |
| Q45076914 | Screening for associated autoimmune disorders in Polish patients with Addison's disease. |
| Q86862624 | Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves' disease |
| Q38181216 | Severe fetal and neonatal hyperthyroidism years after surgical treatment of maternal Graves' disease |
| Q89661576 | Shifting Trends and Informed Decision-Making in the Management of Graves' Disease |
| Q26749195 | THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy |
| Q92703994 | The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease |
| Q33575872 | The Role of Thyrotropin Receptor Activation in Adipogenesis and Modulation of Fat Phenotype |
| Q21285043 | The role of thyrotrophin receptor antibody assays in graves' disease |
| Q36243615 | The thyroid, the eyes and the gut: a possible connection |
| Q33650208 | Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases |
| Q21285111 | Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance |
| Q38044052 | Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease? |
| Q38641495 | Thyroid disease in pregnancy: new insights in diagnosis and clinical management |
| Q37069174 | Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up. |
| Q45752074 | Thyroid peroxidase autoantibodies are associated with a lesser likelihood of late reversion to hyperthyroidism after successful non-ablative treatment of Graves' disease in Croatian patients |
| Q33854441 | Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance |
| Q86862626 | Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy |
| Q34199494 | Thyrotoxicosis of Pregnancy |
| Q84109062 | Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: comparison between different methods |
| Q36515453 | Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa |
| Q38367695 | Total thyroid ablation in Graves' orbitopathy |
| Q58792863 | Treatment of Concurrent Thrombotic Thrombocytopenic Purpura and Graves' Disease: A Report on Two Cases |
| Q37992118 | Treatment options for Graves' orbitopathy |
| Q50254727 | Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients |
| Q57159636 | Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review |
| Q84136156 | [Graves' ophthalmopathy from the internist's perspective] |
| Q86075849 | [Hyperthyroidism] |
| Q83835985 | [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology] |
Search more.